Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma 17Leukemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Burkitt Lymphoma 5Lymphoma, Large B-Cell, Diffuse 4Recurrence 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Biphenotypic, Acute 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Hodgkin Disease 2Prostatic Neoplasms 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Down Syndrome 1Dendritic Cell Sarcoma, Interdigitating 1Breast Neoplasms 1

Interventions

Cyclophosphamide 7Etoposide 6fludarabine phosphate 5Methotrexate 5Filgrastim 5Vincristine 4Rituximab 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Antilymphocyte Serum 4Methylprednisolone 3Ifosfamide 3Doxorubicin 3Cytarabine 3Busulfan 3aldesleukin 2Vorinostat 2Prednisone 2Oxaliplatin 2Mycophenolic Acid 2Mercaptopurine 2Melphalan 2Dexamethasone 2Daunorubicin 2Cyclosporine 2Asparaginase 2trioctyl phosphine oxide 1sargramostim 1pevonedistat 1obatoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Dendritic Cell Sarcoma, Interdigitating × Prednisolone × Clear all
NCT00003423 2013-12-19

Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
100 enrolled
LymphoidSarcoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡